APA

Leung T. F., Liu A. P., Lim F. S., Thollot F., Oh H. M. L., Lee B. W., Rombo L., Tan N. C., Rouzier R., De Simoni S., Suryakiran P., Hezareh M., Thomas F., Folschweiller N. & Struyf F. (20180731). Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial. : Vaccine.

Chicago

Leung Ting Fan, Liu Anthony Pak-Yin, Lim Fong Seng, Thollot Franck, Oh Helen May Lin, Lee Bee Wah, Rombo Lars, Tan Ngiap Chuan, Rouzier Roman, De Simoni Stéphanie, Suryakiran Pemmaraju, Hezareh Marjan, Thomas Florence, Folschweiller Nicolas and Struyf Frank. 20180731. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial. : Vaccine.

Harvard

Leung T. F., Liu A. P., Lim F. S., Thollot F., Oh H. M. L., Lee B. W., Rombo L., Tan N. C., Rouzier R., De Simoni S., Suryakiran P., Hezareh M., Thomas F., Folschweiller N. and Struyf F. (20180731). Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial. : Vaccine.

MLA

Leung Ting Fan, Liu Anthony Pak-Yin, Lim Fong Seng, Thollot Franck, Oh Helen May Lin, Lee Bee Wah, Rombo Lars, Tan Ngiap Chuan, Rouzier Roman, De Simoni Stéphanie, Suryakiran Pemmaraju, Hezareh Marjan, Thomas Florence, Folschweiller Nicolas and Struyf Frank. Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial. : Vaccine. 20180731.